Literature DB >> 28287107

Dying cells actively regulate adaptive immune responses.

Nader Yatim1, Sean Cullen2, Matthew L Albert1,2.   

Abstract

Dying cells have an important role in the initiation of CD8+ T cell-mediated immunity. The cross-presentation of antigens derived from dying cells enables dendritic cells to present exogenous tissue-restricted or tumour-restricted proteins on MHC class I molecules. Importantly, this pathway has been implicated in multiple autoimmune diseases and accounts for the priming of tumour antigen-specific T cells. Recent data have revealed that in addition to antigen, dying cells provide inflammatory and immunogenic signals that determine the efficiency of CD8+ T cell cross-priming. The complexity of these signals has been evidenced by the multiple molecular pathways that result in cell death and that have now been shown to differentially influence antigen transfer and immunity. In this Review, we provide a detailed summary of both the passive and active signals that are generated by dying cells during their initiation of CD8+ T cell-mediated immunity. We propose that molecules generated alongside cell death pathways - inducible damage-associated molecular patterns (iDAMPs) - are upstream immunological cues that actively regulate adaptive immunity.

Entities:  

Mesh:

Year:  2017        PMID: 28287107     DOI: 10.1038/nri.2017.9

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  174 in total

Review 1.  Serial killers: ordering caspase activation events in apoptosis.

Authors:  E A Slee; C Adrain; S J Martin
Journal:  Cell Death Differ       Date:  1999-11       Impact factor: 15.828

2.  RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein.

Authors:  Akhil Rajput; Andrew Kovalenko; Konstantin Bogdanov; Seung-Hoon Yang; Tae-Bong Kang; Jin-Chul Kim; Jianfang Du; David Wallach
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

3.  Drosophila immune deficiency (IMD) is a death domain protein that activates antibacterial defense and can promote apoptosis.

Authors:  P Georgel; S Naitza; C Kappler; D Ferrandon; D Zachary; C Swimmer; C Kopczynski; G Duyk; J M Reichhart; J A Hoffmann
Journal:  Dev Cell       Date:  2001-10       Impact factor: 12.270

4.  Efficient cross-presentation depends on autophagy in tumor cells.

Authors:  Yuhuan Li; Li-Xin Wang; Guojun Yang; Fang Hao; Walter J Urba; Hong-Ming Hu
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

5.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

6.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

7.  Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.

Authors:  A Q Sukkurwala; I Martins; Y Wang; F Schlemmer; C Ruckenstuhl; M Durchschlag; M Michaud; L Senovilla; A Sistigu; Y Ma; E Vacchelli; E Sulpice; X Gidrol; L Zitvogel; F Madeo; L Galluzzi; O Kepp; G Kroemer
Journal:  Cell Death Differ       Date:  2013-06-21       Impact factor: 15.828

8.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

9.  Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation.

Authors:  Nathalie E Blachère; Robert B Darnell; Matthew L Albert
Journal:  PLoS Biol       Date:  2005-04-26       Impact factor: 8.029

10.  The role of heat shock proteins in antigen cross presentation.

Authors:  Ayesha Murshid; Jianlin Gong; Stuart K Calderwood
Journal:  Front Immunol       Date:  2012-03-30       Impact factor: 7.561

View more
  130 in total

1.  Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity.

Authors:  Annelise G Snyder; Nicholas W Hubbard; Michelle N Messmer; Sigal B Kofman; Cassidy E Hagan; Susana L Orozco; Kristy Chiang; Brian P Daniels; David Baker; Andrew Oberst
Journal:  Sci Immunol       Date:  2019-06-21

2.  Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells.

Authors:  Jeonghyun Ahn; Tianli Xia; Ailem Rabasa Capote; Dillon Betancourt; Glen N Barber
Journal:  Cancer Cell       Date:  2018-04-26       Impact factor: 31.743

Review 3.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

4.  Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity.

Authors:  Tik Shing Cheung; Antonio Galleu; Malte von Bonin; Martin Bornhäuser; Francesco Dazzi
Journal:  Haematologica       Date:  2019-03-07       Impact factor: 9.941

5.  Autophagy, apoptosis, and mitochondria: molecular integration and physiological relevance in skeletal muscle.

Authors:  Darin Bloemberg; Joe Quadrilatero
Journal:  Am J Physiol Cell Physiol       Date:  2019-04-24       Impact factor: 4.249

6.  The pros and cons of dying tumour cells in adaptive immune responses.

Authors:  Xiaochen Wang; Xiao-Jie Lu; Beicheng Sun
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

7.  RIPK3 Activation Leads to Cytokine Synthesis that Continues after Loss of Cell Membrane Integrity.

Authors:  Susana L Orozco; Brian P Daniels; Nader Yatim; Michelle N Messmer; Giovanni Quarato; Haiyin Chen-Harris; Sean P Cullen; Annelise G Snyder; Pooja Ralli-Jain; Sharon Frase; Stephen W G Tait; Douglas R Green; Matthew L Albert; Andrew Oberst
Journal:  Cell Rep       Date:  2019-08-27       Impact factor: 9.423

Review 8.  Collateral damage: necroptosis in the development of lung injury.

Authors:  Hilary Faust; Nilam S Mangalmurti
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-27       Impact factor: 5.464

Review 9.  Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.

Authors:  Mariona Cabo; Rienk Offringa; Laurence Zitvogel; Guido Kroemer; Aura Muntasell; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-08-30       Impact factor: 8.110

Review 10.  Gasdermin D (GSDMD) as a new target for the treatment of infection.

Authors:  Ankit Pandeya; Lan Li; Zhenyu Li; Yinan Wei
Journal:  Medchemcomm       Date:  2019-04-04       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.